Targeting the mevalonate pathway in multiple myeloma

被引：3
|
作者：
van der Spek, Ellen [1 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Hematol, NL-3584 CX Utrecht, Netherlands
来源：
LEUKEMIA RESEARCH | 2010年 / 34卷 / 03期
关键词：
Multiple myeloma; Mevalonate pathway; Plasma cell lines; FPP; GGPP; CELL-LINES; DRUG-RESISTANCE; PLASMA-CELLS; APOPTOSIS; SIMVASTATIN; INHIBITOR; SURVIVAL; PROTEIN; GERANYLGERANYLATION; FARNESYLATION;
D O I：
10.1016/j.leukres.2009.07.027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：267 / 268
页数：2
相关论文
共 50 条
  • [41] Targeting MET transcription as a therapeutic strategy in multiple myeloma
    Cornel J. Phillip
    Christine M. Stellrecht
    Ramadevi Nimmanapalli
    Varsha Gandhi
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 587 - 597
  • [42] Targeting Intrinsic and Extrinsic Vulnerabilities for the Treatment of Multiple Myeloma
    Anreddy, Nagaraju
    Hazlehurst, Lori A.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2017, 118 (01) : 15 - 25
  • [43] Targeting Nuclear Export Proteins in Multiple Myeloma Therapy
    Theodoropoulos, Nicholas
    Lancman, Guido
    Chari, Ajai
    TARGETED ONCOLOGY, 2020, 15 (06) : 697 - 708
  • [44] Antitumor activity of CDA-., a urinary preparation, on human multiple myeloma cell lines via the mitochondrial pathway
    Yang, Min
    Huang, Jian
    Ma, Qiu-Ling
    Xu, Gai-Xiang
    Jin, Jie
    MOLECULAR MEDICINE REPORTS, 2014, 9 (03) : 1025 - 1031
  • [45] Cholesterol-Lowering Phytochemicals: Targeting the Mevalonate Pathway for Anticancer Interventions
    Laka, Kagiso
    Makgoo, Lilian
    Mbita, Zukile
    FRONTIERS IN GENETICS, 2022, 13
  • [46] Targeting an MDM2/MYC Axis to Overcome Drug Resistance in Multiple Myeloma
    Faruq, Omar
    Zhao, Davidson
    Shrestha, Mariusz
    Vecchione, Andrea
    Zacksenhaus, Eldad
    Chang, Hong
    CANCERS, 2022, 14 (06)
  • [47] Targeting coenzyme Q10 synthesis overcomes bortezomib resistance in multiple myeloma
    Zaal, Esther A.
    De Grooth, Harm-Jan
    Oudaert, Inge
    Langerhorst, Pieter
    Levantovsky, Sophie
    van Slobbe, Gijs J. J.
    Jansen, Jeroen W. A.
    Menu, Eline
    Wu, Wei
    Berkers, Celia R.
    MOLECULAR OMICS, 2022, 18 (01) : 19 - 30
  • [48] Combined targeting of MEK and the glucocorticoid receptor for the treatment of RAS-mutant multiple myeloma
    Sriskandarajah, Priya
    De Haven Brandon, Alexis
    MacLeod, Kenneth
    Carragher, Neil O.
    Kirkin, Vladimir
    Kaiser, Martin
    Whittaker, Steven R.
    BMC CANCER, 2020, 20 (01)
  • [49] Hypoxia and Activated VEGF/Receptor Pathway in Multiple Myeloma
    Giatromanolaki, Alexandra
    Bai, Maria
    Margaritis, Dimitrios
    Bourantas, Konstantinos L.
    Koukourakis, Michael I.
    Sivridis, Efthimios
    Gatter, Kevin C.
    ANTICANCER RESEARCH, 2010, 30 (07) : 2831 - 2836
  • [50] p38 Molecular Targeting for Next-Generation Multiple Myeloma Therapy
    Morales-Martinez, Mario
    Vega, Mario I.
    CANCERS, 2024, 16 (02)
12345